Clinical Roundup Novel liquid biopsy methodology can track evolution of metastatic prostate cancer July 26, 2024Vol.50 No.30
Drugs & Targets FDA accepts Telix’s NDA for prostate cancer imaging agent July 26, 2024Vol.50 No.30
Clinical Roundup Nubeqa + androgen deprivation therapy improves rPFS for mHSPC in phase III trial July 19, 2024Vol.50 No.29
Clinical Roundup Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men July 19, 2024Vol.50 No.29
Clinical Roundup AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy July 19, 2024Vol.50 No.29
In Brief UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy July 12, 2024Vol.50 No.28
Drugs & Targets FDA grants Fast Track designation to 225Ac-FL-020 radiopharmaceutical for mCRPC July 12, 2024Vol.50 No.28
Clinical Roundup AI improves physicians’ ability to identify prostate cancer extent June 14, 2024Vol.50 No.24
Clinical Roundup AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy May 10, 2024Vol.50 No.19
Clinical Roundup AI tool predicts success of focal therapy for prostate cancer May 10, 2024Vol.50 No.19
